openPR Logo
Press release

Malignant Mesothelioma Market to Exceed US$ 600 Mn in 2025

Malignant Mesothelioma Market to Exceed US$ 600 Mn in 2025

In developed countries, discretionary research funding for cancer is on a rise. Increased investments towards development of better treatment against malignant mesothelioma is observed globally. Persistence Market Research’s new report on global market for malignant mesothelioma predicts that governments will increase their focus towards creating awareness about mesothelioma in the future. The global malignant mesothelioma market is expected to incur favorable boost from increased healthcare spending witnessed in multiple parts of the world, coupled with availability of better treatment prognosis for mesothelioma.

Request to Sample of Report @  https://www.persistencemarketresearch.com/samples/10628

In 2017, the global malignant mesothelioma market is expected to reach a value of US$ 338 Mn. The report observes that increasing use of asbestos for commercial purposes is fuelling the incidence of malignant mesothelioma among people. By the end of 2025, the global market for malignant mesothelioma is anticipated to have soared at 7.5% CAGR, reaching an estimated US$ 604 Mn in value.

Request for Table of Contents @ https://www.persistencemarketresearch.com/market-research/malignant-mesothelioma-market/toc

Global Malignant Mesothelioma Market – Prominent Trends

Studies focused on cause of malignant mesothelioma are being publicized to boost awareness. Through such work, people are becoming more aware, particularly with respect to association of the HOXB4 gene is stopping the maturation of mesothelioma tumor. Overall, the global market for malignant mesothelioma is also witnessing an increased adoption of combination therapies. Many companies are promoting the cumulative use of chemotherapy and immune-oncology procedures in treatment of malignant mesothelioma.

Request Report Multiple Chapter @ https://www.persistencemarketresearch.com/multiple-chapter/10628

In addition to this, malignant mesothelioma is gaining incidence among men. Exposure to asbestos is likely to remain concentrated to male demographics of the world. Increased exposure to such toxic elements is aggravating the incidence of mesothelioma in men. Key players in the global malignant mesothelioma market are also collaborating with leading research organizations to develop combination drugs on mesothelioma, the approval of which is drawing highest regard of authorities such as the FDA. The report has profiled leading players in the global malignant mesothelioma market, and they include Sanofi, Eli Lilly and Company, Teva Pharmaceuticals, Boehringer Ingelheim GmbH, Mylan N.V., Fresenius Kabi AG, Sun Pharmaceuticals Industries Ltd., Corden Pharma International GmbH, Concordia International Corp., Kyowa Hakko Kirin Co Ltd., Polaris Pharmaceuticals, Inc., MolMed SpA, Ono Pharmaceutical Co. Ltd., Nichi-Iko Pharmaceutical Co., Ltd., AstraZeneca Plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Novartis AG, and Pfizer Inc.

For more information @ https://www.prnewswire.com/news-releases/global-malignant-mesothelioma-market-to-reach-us-600-mn-by-2025---persistence-market-research-634257773.html

Malignant Mesothelioma Market Forecast – Key Findings

The demand for malignant mesothelioma treatment is expected to be high in the Asia-Pacific (APAC) region. Higher exposure to asbestos across APAC industries is driving this demand as the region is anticipated to record fastest growth at 8% CAGR.

Pemetrexed drugs are gaining traction, globally, sales of which are expected to account for more than 45% revenue share through 2025.

Throughout the forecast period, revenues accounted by parenteral administration of malignant mesothelioma drugs is expected to be over 90% of global market revenues.

The report also projects that hospital pharmacies will be largest distribution channel in the global malignant mesothelioma market, accounting for around 50% of global sales at any point of the forecast period.

Get full report now @ https://www.persistencemarketresearch.com/checkout/10628

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Malignant Mesothelioma Market to Exceed US$ 600 Mn in 2025 here

News-ID: 1032317 • Views:

More Releases from Persistence Market Research pvt ltd

Rise of Cloud Computing and Big Data Analytics Drives Processor Market Growth to US$ 332.0 billion by 2033
Rise of Cloud Computing and Big Data Analytics Drives Processor Market Growth to …
According to a recent report by Persistence Market Research, the global processor market is expected to reach a value of US$ 332.0 billion by 2033, growing at a CAGR of approximately 9.6% during the forecast period. The increasing demand for processors in smartphones, tablets, and other mobile devices is a key driver of market growth. The report also notes that the demand for processors in the automotive industry is expected
Building Products Market Expected to Grow at 5.2% CAGR to Reach USD 1.5 Trillion by 2026
Building Products Market Expected to Grow at 5.2% CAGR to Reach USD 1.5 Trillion …
the global building products market size was valued at USD 1.1 trillion and is expected to reach USD 1.5 trillion by 2026, growing at a CAGR of 5.2% during the forecast period. The building products market encompasses a wide range of products used in the construction and renovation of residential, commercial, and industrial buildings. These products include but are not limited to lumber and wood products, roofing materials, insulation, windows and
Road Sweeping Machine Market Size to Surpass US$ 5.9 billion by 2028 | Persistence Market Research
Road Sweeping Machine Market Size to Surpass US$ 5.9 billion by 2028 | Persisten …
Road Sweeping Machine Market The global road sweeping machine market is expected to reach a value of US$ 5.9 billion by 2028, growing at a CAGR of 6.5% from 2023 to 2028. The market growth is driven by several factors such as urbanization, increasing infrastructure development, rising awareness about environmental cleanliness, and government initiatives to promote sustainable living. Click Here to Get Free Sample Copy of this Report @https://www.persistencemarketresearch.com/samples/16750 Road sweeping machines are
Pigments & Dyes Market is expected to grow at a CAGR of 4.3% from 2023 to 2028
Pigments & Dyes Market is expected to grow at a CAGR of 4.3% from 2023 to 2028
Pigments & Dyes Market The global pigments and dyes market was valued at US$ 27.8 billion in 2022 and is expected to grow at a CAGR of 4.3% from 2022 to 2028, according to a report by PMR. The growth in the market can be attributed to the increasing demand for pigments and dyes from end-use industries such as textiles, paints, coatings, and plastics. The demand for high-performance pigments and dyes

All 5 Releases


More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986 Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications